Back

Dementia in patients with type 2 diabetes: a nationwide Danish study

30 August 2026 (14:40 - 14:50)
Organised by: Logo
Congress Presentation Part of: Unexpected consequences of cardiometabolic disease Diabetes and the Heart ESC Professional Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Ms Helene Christensen

(Denmark)

2 More presentations in this session

Presentation thumbnail
SGLT2 inhibitor empagliflozin remodels pericardial fat–derived lipids-initiated ventricular ion‑channel function to reduce arrhythmogenic electrical remodeling in diabetic hearts
Doctor Y. Lin (Kaohsiung, TW)
Abstract Slides Video
Presentation thumbnail
Finerenone with empagliflozin according to body mass index in chronic kidney disease and type 2 diabetes
Doctor J. Ostrominski (Boston, US)
Abstract Slides Video

Access the full session

Session thumbnail
Unexpected consequences of cardiometabolic disease
Video

The Event

Event poster

ESC Congress 2026

30 August 2026 14:40 CET
You may be interested in
thumbnail
Congress Presentation
Risk of dementia and mortality in patients with heart failure - a danish nationwide cohort study
31 August 2026
thumbnail
Congress Session
Diabetes and acute coronary syndrome
28 August 2026
thumbnail
Congress Presentation
Dementia in cardiometabolic disease: prevention and treatment
30 August 2026
thumbnail
Congress Presentation
Timing of statin treatment following diabetes diagnosis on risk of dementia: a nationwide study
30 August 2026

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources